CompletedNCT05870540
What is this study about?This study evaluated the safety and effectiveness of BPL-003 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamDepressionMedication studyAges 18–75
- Countries
- United States, Australia, United Kingdom, + 3 others
- Sponsor
- Beckley Psytech Limited
Active Not RecruitingNCT01984710
Official study titleDeep Brain Stimulation for Treatment Resistant Depression: Exploration of Local Field Potentials (LFP) With the Medtronic Activa Primary Cell + Sensing (PC+S) "Brain Radio" System
This study is no longer accepting new participants.
In AtlantaDepressionDevice studyAges 25–70
- Countries
- United States
- Sponsor
- Emory University
WithdrawnNCT03290963
Official study titleTargeting mTOR/GSK3 With Lithium Augmentation to Enhance and Sustain Rapid Antidepressant Actions of Ketamine in Adults With Treatment-Resistant Depression: A Precision Medicine Approach for Psychiatry
This study was withdrawn before enrollment.
In RochesterDepressionMedication studyAges 18–64
- Countries
- United States
- Sponsor
- William V. Bobo, M.D.
Active Not RecruitingNCT00565617
Official study titleA Pilot Safety and Efficacy Study of Epidural Prefrontal Cortical Stimulation (EpCS) in Severe Treatment Resistant Depression
This study is no longer accepting new participants.
In CharlestonDepressionDevice studyAges 21–80
- Countries
- United States
- Sponsor
- Medical University of South Carolina
CompletedNCT05913401
Official study titleAerobic Exercise to Augment the Plasticity Effect of rTMS in Patients With Treatment-resistant Depression
This study has finished and is no longer accepting participants.
In ProvidenceDepressionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Butler Hospital
CompletedNCT06620042
Official study titleFunctional Magnetic Resonance Imaging of Patients Receiving Intravenous Ketamine for Treatment Resistant Bipolar Depression
This study has finished and is no longer accepting participants.
Multiple locations, including ClevelandDepression, BipolarityMedication studyAges 18–75
- Countries
- United States
- Sponsor
- Drew Cumming
UnknownNCT05595356
Official study titleHome-based Transcranial Direct Current Stimulation (tDCS) for Treatment Resistant Depression: a Randomized Clinical Trial
Current recruitment status is unconfirmed.
In Porto AlegreDepressionDevice studyAges 18+
- Countries
- Brazil
- Sponsor
- Hospital de Clinicas de Porto Alegre
CompletedNCT06166082
Official study titleIntensive Accelerated Intermittent Theta Burst Stimulation in Treatment-resistant Depression: A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Trial
This study has finished and is no longer accepting participants.
Multiple locations, including BaodingDepressionDevice studyAges 22–65
- Countries
- China
- Sponsor
- Changping Laboratory
CompletedNCT06138691
Official study titleMedication-assisted Psychotherapy: Using Ketamine-enhanced Radically Open Dialectical Behavior Therapy (RO DBT) to Target Neural and Behavioral Mechanisms of Action in Adults With Moderate to Severe Depression
This study has finished and is no longer accepting participants.
In St LouisDepressionInterventional studyAges 18–65
- Countries
- United States
- Sponsor
- Washington University School of Medicine
CompletedNCT03947827
What is this study about?This study assessed depression symptoms.
This study has finished and is no longer accepting participants.
In TorontoDepressionMedication studyAges 18–80
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT03428828
Official study titleAmygdala rtfMRI Neurofeedback for Treatment Resistant Depression
This study has finished and is no longer accepting participants.
In PittsburghDepressionDevice studyAges 18–55
- Countries
- United States
- Sponsor
- Kymberly Young
SuspendedNCT05842291
Official study titlePersonalized Brain Functional Sectors (pBFS) Guided High-dose rTMS Therapy for Treatment-resistant Depression: A Randomized, Double-Blind, Sham-controlled Trial
Recruitment is currently suspended.
In BeijingDepressionDevice studyAges 18–65
- Countries
- China
- Sponsor
- Changping Laboratory